Cytosorbents Inventory Turnover Ratio 2007-2019 | CTSO
Cytosorbents inventory turnover ratio from 2007 to 2019. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period.
| Cytosorbents Inventory Turnover Ratio Historical Data | |||
|---|---|---|---|
| Date | |||
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.210B | $0.023B |
| CytoSorbents Corporation is a therapeutic medical device company. It develops adsorbent polymer technology for applications in the medical field, primarily to provide blood purification for the treatment of acute and chronic health complications associated with blood toxicity. The Company's product include CytoSorb, which filters cytokines and treat potentially fatal cytokine storm and BetaSorb, which remove beta2-microglobulin from the blood of patients suffering from chronic kidney failure. CytoSorbents Corporation is headquartered in Monmouth Junction, New Jersey. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $149.955B | 29.11 |
| Medtronic (MDT) | Ireland | $133.284B | 19.04 |
| Stryker (SYK) | United States | $75.636B | 26.99 |
| Boston Scientific (BSX) | United States | $57.976B | 27.79 |
| Baxter (BAX) | United States | $42.043B | 26.50 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.226B | 15.56 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $19.156B | 0.00 |
| ResMed (RMD) | United States | $17.217B | 32.90 |
| Canopy Growth (CGC) | Canada | $13.835B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.076B | 48.12 |
| Aurora Cannabis (ACB) | Canada | $7.403B | 73.00 |
| Insulet (PODD) | United States | $7.147B | 520.74 |
| Hill-Rom Holdings (HRC) | United States | $6.992B | 21.20 |
| Perrigo (PRGO) | Ireland | $6.052B | 10.23 |
| Haemonetics (HAE) | United States | $6.021B | 49.14 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $5.237B | 0.00 |
| ICU Medical (ICUI) | United States | $5.130B | 30.61 |
| Hutchison China MediTech (HCM) | China | $3.814B | 0.00 |
| Neogen (NEOG) | United States | $3.238B | 52.65 |
| Agios Pharmaceuticals (AGIO) | United States | $2.981B | 0.00 |
| NuVasive (NUVA) | United States | $2.962B | 24.19 |
| National Vision Holdings (EYE) | United States | $2.499B | 53.25 |
| Quidel (QDEL) | United States | $2.360B | 24.49 |
| Aphria (APHA) | $1.687B | 0.00 | |
| Cardiovascular Systems (CSII) | United States | $1.495B | 858.80 |
| Phibro Animal Health (PAHC) | United States | $1.220B | 18.28 |
| AtriCure (ATRC) | United States | $1.159B | 0.00 |
| VAREX IMAGING (VREX) | United States | $1.119B | 23.75 |
| Lantheus Holdings (LNTH) | United States | $1.081B | 28.71 |
| OrganiGram Holdings (OGI) | Canada | $0.993B | 0.00 |
| NanoString Technologies (NSTG) | United States | $0.935B | 0.00 |
| PetIQ (PETQ) | United States | $0.899B | 21.84 |
| Quanterix (QTRX) | United States | $0.846B | 0.00 |
| MacroGenics (MGNX) | United States | $0.812B | 0.00 |
| Omeros (OMER) | United States | $0.794B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.771B | 21.61 |
| Cerus (CERS) | United States | $0.682B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.638B | 0.00 |
| Surmodics (SRDX) | United States | $0.572B | 83.20 |
| OraSure Technologies (OSUR) | United States | $0.552B | 25.40 |
| LeMaitre Vascular (LMAT) | United States | $0.545B | 26.37 |
| Meridian Bioscience (VIVO) | United States | $0.489B | 14.95 |
| Evolus (EOLS) | United States | $0.371B | 0.00 |
| Vapotherm (VAPO) | United States | $0.364B | 0.00 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.355B | 0.00 |
| Zynex (ZYXI) | United States | $0.355B | 36.73 |
| BioLife Solutions (BLFS) | United States | $0.311B | 97.41 |
| Utah Medical Products (UTMD) | United States | $0.302B | 20.93 |
| Bovie Medical (APYX) | United States | $0.217B | 0.00 |
| Owens & Minor (OMI) | United States | $0.193B | 4.08 |
| Chimerix (CMRX) | United States | $0.173B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.172B | 0.00 |
| Fonar (FONR) | United States | $0.140B | 7.38 |
| Female Health (VERU) | United States | $0.134B | 0.00 |
| BRAINSWAY LTD (BWAY) | Israel | $0.111B | 0.00 |
| Neurotrope (NTRP) | United States | $0.100B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.100B | 0.00 |
| Surface Oncology (SURF) | United States | $0.088B | 0.00 |
| United-Guardian (UG) | United States | $0.087B | 19.21 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.062B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| Senestech (SNES) | United States | $0.039B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.039B | 13.58 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.031B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.030B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.021B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.015B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.012B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.007B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.007B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.005B | 3.73 |
